Brousse et al reported markers of disease severity in infants with sickle cell anemia. These can identify a patient who may benefit from more aggressive management. The authors are from multiple institutions in France, London and New York City.
Patient selection: infant with hemoglobin SS or hemoglobin S-beta thalassemia (beta-0)